[Corticoid-induced osteoporosis. Pathogenesis, diagnosis and treatment].
Negri
A L
AL
Instituto de Investigaciones Metabólicas, Buenos Aires, Argentina.
Spivacow
F R
FR
Zanchetta
J R
JR
D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000494:pharmacology; D000328:Adult; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D002118:Calcium / Q000627:therapeutic use / Q000652:urine; D002136:Calcium, Dietary / Q000493:pharmacokinetics; D005260:Female; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000139:chemically induced; D015994:Incidence; D007408:Intestinal Absorption / Q000187:drug effects; D007684:Kidney Tubules / Q000187:drug effects / Q000378:metabolism; D008297:Male; D010024:Osteoporosis / Q000139:chemically induced* / Q000175:diagnosis / Q000453:epidemiology / Q000378:metabolism / Q000628:therapy; D010758:Phosphorus / Q000652:urine; D011446:Prospective Studies; D012307:Risk Factors; D014807:Vitamin D / Q000493:pharmacokinetics / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D002136:Calcium, Dietary; D014807:Vitamin D; D010758:Phosphorus; D002118:Calcium
Osteoporosis inducida por corticoides. Patogénesis, diagnóstico y tratamiento.